» Articles » PMID: 32377202

Enhanced Effect of IL-1-Activated Adipose-Derived MSCs (ADMSCs) on Repair of Intestinal Ischemia-Reperfusion Injury Via COX-2-PGE Signaling

Overview
Journal Stem Cells Int
Publisher Wiley
Specialty Cell Biology
Date 2020 May 8
PMID 32377202
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Adipose-derived mesenchymal stem cells (ADMSCs) have been used for treating tissue injury, and preactivation enhances their therapeutic effect. This study is aimed at investigating the therapeutic effect of activated ADMSCs by IL-1 on the intestinal ischaemia-reperfusion (IR) injury and exploring potential mechanisms. ADMSCs were pretreated with IL-1 in vitro, and activation of ADMSCs was assessed by -SMA and COX-2 expressions and secretary function. Activated ADMSCs was transplanted into IR-injured intestine in a mouse model, and therapeutic effect was evaluated. In addition, to explore underlying mechanisms, COX-2 expression was silenced to investigate its role in activated ADMSCs for treatment of intestinal IR injury. When ADMSCs were pretreated with 50 ng/ml IL-1 for 24 hr, expressions of -SMA and COX-2 were significantly upregulated, and secretions of PGE, SDF-1, and VEGF were increased. When COX-2 was silenced, the effect of IL-1 treatment was abolished. Activated ADMSCs with IL-1 significantly suppressed inflammation and apoptosis and enhanced healing of intestinal IR injury in mice, and these effects were impaired by COX-2 silencing. The results of RNA sequencing suggested that compared with the IR injury group activated ADMSCs induced alterations in mRNA expression and suppressed the activation of the NF-B-P65, MAPK-ERK1/2, and PI3K-AKT pathways induced by intestinal IR injury, whereas silencing COX-2 impaired the suppressive effect of activated ADMSCs on these pathway activations induced by IR injury. These data suggested that IL-1 pretreatment enhanced the therapeutic effect of ADMSCs on intestinal IR injury repairing via activating ADMSC COX-2-PGE signaling axis and via suppressing the NF-B-P65, MAPK-ERK1/2, and PI3K-AKT pathways in the intestinal IR-injured tissue.

Citing Articles

Adipose-derived stem cells in immune-related skin disease: a review of current research and underlying mechanisms.

Sun T, Zhou C, Lu F, Dong Z, Gao J, Li B Stem Cell Res Ther. 2024; 15(1):37.

PMID: 38331803 PMC: 10854049. DOI: 10.1186/s13287-023-03561-8.


TNF-α/IL-1β-licensed hADSCs alleviate cholestatic liver injury and fibrosis in mice via COX-2/PGE2 pathway.

Luan X, Chen P, Li Y, Yuan X, Miao L, Zhang P Stem Cell Res Ther. 2023; 14(1):100.

PMID: 37095581 PMC: 10127380. DOI: 10.1186/s13287-023-03342-3.


Transplanted hair follicle mesenchymal stem cells alleviated small intestinal ischemia-reperfusion injury intrinsic and paracrine mechanisms in a rat model.

Gao Y, Chen H, Cang X, Chen H, Di Y, Qi J Front Cell Dev Biol. 2022; 10:1016597.

PMID: 36274835 PMC: 9581151. DOI: 10.3389/fcell.2022.1016597.


Recent advances to enhance the immunomodulatory potential of mesenchymal stem cells.

Sarsenova M, Kim Y, Raziyeva K, Kazybay B, Ogay V, Saparov A Front Immunol. 2022; 13:1010399.

PMID: 36211399 PMC: 9537745. DOI: 10.3389/fimmu.2022.1010399.


Mesenchymal stem cells against intestinal ischemia-reperfusion injury: a systematic review and meta-analysis of preclinical studies.

Shi Y, Zhang X, Wan Z, Liu X, Chen F, Zhang J Stem Cell Res Ther. 2022; 13(1):216.

PMID: 35619154 PMC: 9137086. DOI: 10.1186/s13287-022-02896-y.


References
1.
Wu R, Hu X, Wang J . Concise Review: Optimized Strategies for Stem Cell-Based Therapy in Myocardial Repair: Clinical Translatability and Potential Limitation. Stem Cells. 2018; 36(4):482-500. DOI: 10.1002/stem.2778. View

2.
Mei S, Wang S, Jin S, Zhao X, Shao Z, Zhang R . Human Adipose Tissue-Derived Stromal Cells Attenuate the Multiple Organ Injuries Induced by Sepsis and Mechanical Ventilation in Mice. Inflammation. 2018; 42(2):485-495. DOI: 10.1007/s10753-018-0905-5. View

3.
Hsu W, Lin C, Chiang B, Jui H, Wu K, Lee C . Prostaglandin E2 potentiates mesenchymal stem cell-induced IL-10+IFN-γ+CD4+ regulatory T cells to control transplant arteriosclerosis. J Immunol. 2013; 190(5):2372-80. DOI: 10.4049/jimmunol.1202996. View

4.
Wu C, Chen L, Huang Y, Huang Y, Parolini O, Zhong Q . Comparison of the Proliferation and Differentiation Potential of Human Urine-, Placenta Decidua Basalis-, and Bone Marrow-Derived Stem Cells. Stem Cells Int. 2019; 2018:7131532. PMC: 6311712. DOI: 10.1155/2018/7131532. View

5.
Xu P, Yang X . The Efficacy and Safety of Mesenchymal Stem Cell Transplantation for Spinal Cord Injury Patients: A Meta-Analysis and Systematic Review. Cell Transplant. 2018; 28(1):36-46. PMC: 6322141. DOI: 10.1177/0963689718808471. View